200+ lawsuits allege GLP-1 weight-loss drugs Ozempic, Wegovy and Zepbound caused sudden vision loss

More than 200 lawsuits now allege that popular GLP-1 weight-loss drugs including Ozempic, Wegovy and Zepbound caused NAION, a rare form of sudden vision loss that cuts blood flow to the optic nerve and can cause permanent blindness. Novo Nordisk is named among the companies involved.

Detected & updated continuously · Source: Nebula

Story subjects

Novo NordiskOzempicWegovyZepboundGLP-1 receptor agonists

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula